Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage cervical cancer
References
Additional references
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub‐committee of the International Continence Society. Urology 2003;61(1):37‐49.
Barry MJ, Fowler FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. Journal of Urology 1992;148(5):1549–57.
Chen GD, Lin LY, Wang PH, Lee HS. Urinary tract dysfunction after radical hysterectomy for cervical cancer. Gynecologic Oncology 2002;85(2):292‐7.
US Department of Health and Human Services (National Institutes of Health, National Cancer Institute). Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03. evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf (accessed 16 October 2017).
Cull A, Cowie VJ, Farquharson DI, Livingstone JR, Smart GE, Elton RA. Early stage cervical cancer: psychosocial and sexual outcomes of treatment. British Journal of Cancer 1993;68(6):1216‐20.
Deeks J, Altman D, Bradburn M. Statistical methods for examining heterogeneity and combining results from several studies in meta‐analysis. 2. London: BMJ Publication Group, 2001.
DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88.
Thomas Reuters. Endnote. Version X7. New York: Thomas Reuters, 2015.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer 2015;136(5):E359‐86.
Fernandez RS, Griffiths RD. Clamping short‐term indwelling catheters: a systematic review of the evidence. Journal of Wound, Ostomy and Continence Nursing 2005;32(5):329‐36.
FIGO Committee on Gynecologic Oncology. FIGO staging for carcinoma of the vulva, cervix, and corpus uteri. International Journal of Gynaecology and Obstetrics 2014;125(2):97‐8.
Geller EJ. Prevention and management of postoperative urinary retention after urogynecologic surgery. International Journal of Women's Health 2014;6:829‐38.
International Agency for Research on Cancer. GLOBOCAN 2012: Estimated Cancer Incidence and Mortality Worldwide in 2012. globocan.iarc.fr (accessed 3 November 2017).
Goldfarb M, Medina‐Cue R. Urologic complications of abdominoperineal surgery. Diseases of the Colon and Rectum 1967;10(5):379‐83.
McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 3 November 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.
Greimel ER, Kuljanic Vlasic K, Waldenstrom AC, Duric VM, Jensen PT, Singer S. The European Organization for Research and Treatment of Cancer (EORTC) Quality‐of‐Life questionnaire cervical cancer module: EORTC QLQ‐CX24. Cancer 2006;107(8):1812‐22.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60.
Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Kemp B, Kitschke HJ, Goetz M, Heyl W. Prophylaxis and treatment of bladder dysfunction after Wertheim‐Meigs operation: the positive effect of early postoperative detrusor stimulation using the cholinergic drug betanechol chloride. International Urogynecology Journal 1997;8(3):138‐41.
Kidd EA, Stewart F, Kassis NC, Hom E, Omar MI. Urethral (indwelling or intermittent) or suprapubic routes for short‐term catheterisation in hospitalised adults. Cochrane Database of Systematic Reviews 2015, Issue 12. [DOI: 10.1002/14651858.CD004203.pub3]
Kim SM, Choi HS, Byun JS. Overall 5‐year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. International Journal of Gynecologic Cancer 2000;10(4):305‐12.
Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, et al. Randomised study of radical surgery versus radiotherapy for stage Ib‐IIa cervical cancer. Lancet 1997;350(9077):535‐40.
Landoni F, Maneo A, Cormio G, Perego P, Milani R, Caruso O, et al. Class II versus class III radical hysterectomy in stage IB‐IIA cervical cancer: a prospective randomized study. Gynecologic Oncology 2001;80(1):3‐12.
Langendam MW, Akl EA, Dahm P, Glasziou P, Guyatt G, Schünemann HJ. Assessing and presenting summaries of evidence in Cochrane Reviews. Systematic Reviews 2013;2:81.
Laterza RM, Sievert KD, de Ridder D, Vierhout ME, Haab F, Cardozo L, et al. Bladder function after radical hysterectomy for cervical cancer. Neurourology and Urodynamics 2015;34(4):309‐15.
Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. BMJ 2009;339:2700.
Lin HH, Sheu BC, Lo MC, Huang SC. Abnormal urodynamic findings after radical hysterectomy or pelvic irradiation for cervical cancer. International Journal of Gynecology and Obstetrics 1998;63(2):169‐74.
Madeiro AP, Rufino AC, Sartori MG, Baracat EC, Lima GR, Girao MJ. The effects of bethanechol and cisapride on urodynamic parameters in patients undergoing radical hysterectomy for cervical cancer. International Urogynecology Journal and Pelvic Floor Dysfunction 2006;17(3):248‐52.
Mahawerawat S, Charoenkwan K, Srisomboon J, Khunamornpong S, Suprasert P, Sae‐Teng CT. Surgical outcomes of patients with stage IA2 cervical cancer treated with radical hysterectomy. Asian Pacific Journal of Cancer Prevention 2013;14(9):5375‐8.
Manchana T, Prasartsakulchai C, Santingamkun A. Long‐term lower urinary tract dysfunction after radical hysterectomy in patients with early postoperative voiding dysfunction. International Urogynecology Journal and Pelvic Floor Dysfunction 2010;21(1):95‐101.
Naik R, Maughan K, Nordin A, Lopes A, Godfrey KA, Hatem MH. A prospective randomised controlled trial of intermittent self‐catheterisation vs. supra‐pubic catheterisation for post‐operative bladder care following radical hysterectomy. Gynecologic Oncology 2005;99(2):437‐42.
Oberst MT, Graham D, Geller NL, Stearns MW, Tiernan E. Catheter management programs and postoperative urinary dysfunction. Research in Nursing & Health 1981;4(1):175‐81.
Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815‐34.
Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstetrics & Gynecology 1974;44(2):265‐72.
Plotti F, Angioli R, Zullo MA, Sansone M, Altavilla T, Antonelli E, et al. Update on urodynamic bladder dysfunctions after radical hysterectomy for cervical cancer. Critical Reviews in Oncology Hematology 2011;80(2):323‐9.
Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncology 2008;9(3):297‐303.
Raspagliesi F, Ditto A, Fontanelli R, Zanaboni F, Solima E, Spatti G, et al. Type II versus type III nerve‐sparing radical hysterectomy: comparison of lower urinary tract dysfunctions. Gynecologic Oncology 2006;102(2):256‐62.
The Nordic Cochrane Centre, The CochraneCollaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and ‘Summary of findings’ tables. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Sellers DJ, Chess‐Williams R. Muscarinic agonists and antagonists: effects on the urinary bladder. Handbook of Experimental Pharmacology 2012, (208):375‐400.
Srisomboon J, Kietpeerakool C, Suprasert P, Manopanya M, Siriaree S, Charoenkwan K, et al. Survival and prognostic factors comparing stage IB 1 versus stage IB 2 cervical cancer treated with primary radical hysterectomy. Asian Pacific Journal of Cancer Prevention 2011;12(7):1753‐6.
Sterne J, Sutton A, Loannidis J, Terrin N, Jones D, Lau J. Recommendations for examining and interpreting funnel plot asymmetry in meta‐analyses of randomised controlled trials. BMJ 2011;343:d4002.
Suprasert P, Srisomboon J, Charoenkwan K, Siriaree S, Cheewakriangkrai C, Kietpeerakool C, et al. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer. Journal of Obstetrics Gynaecology 2010;30(3):294‐8.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet‐Tieulent J, Jemal A. Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians 2015;65(2):87‐108.
Verleye L, Vergote I, Reed N, Ottevanger PB. Quality assurance for radical hysterectomy for cervical cancer: the view of the European Organization for Research and Treatment of Cancer‐‐Gynecological Cancer Group (EORTC‐GCG). Annals of Oncology 2009;20(10):1631‐8.
Viswanathan AN, Lee LJ, Eswara JR, Horowitz NS, Konstantinopoulos PA, Mirabeau‐Beale KL, Rose BS, et al. Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer 2014;15(120):24.
Wallace SA, Roe B, Williams K, Palmer M. Bladder training for urinary incontinence in adults. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD001308.pub2]
Wang XY. Effect of acupuncture on bladder function in patients with radical hysterectomy. Zhen Ci Yan Jiu 2007;32(2):132‐5.
Wit EM, Horenblas S. Urological complications after treatment of cervical cancer. Nature Reviews Urology 2014;11(2):110‐7.
Yi WM, Pan AZ, Li JJ, Luo DF, Huang QH. Clinical observation on the acupuncture treatment in patients with urinary retention after radical hysterectomy. Chinese Journal of Integrative Medicine 2011;17(11):860‐3.
Zhou W, Yang X, Dai Y, Wu Q, He G, Yin G. Survey of cervical cancer survivors regarding quality of life and sexual function. Journal of Cancer Research and Therapeutics 2016;12(2):938‐44.
Zullo MA, Manci N, Angioli R, Muzii L, Panici PB. Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review. Critical Reviews in Oncology/Hematology 2003;48(3):287‐93.
